Highmark allegedly wanted to restructure the health system through bankruptcy, which violated the companies’ affiliation agreement. After West Penn entered bankruptcy, Highmark would allegedly measure the market’s reaction to determine whether to proceed with the acquisition, according to West Penn.
The chairman of West Penn’s board, Jack Isherwood, said bankruptcy “is not the first option, it’s the last option,” according to the report. He also said West Penn’s proposed alternatives to bankruptcy were met with “tepid” interest, according to the report.
The system is now looking for new partners and is willing to consider all types of suitors, whether for-profit and non-profit health systems or insurance companies.
Highmark released a statement saying there was not a breach in the affiliation agreement. The payor says continuing the acquisition is in the best interest of both companies. Highmark CEO William Winkenwerder Jr. was alerted of West Penn’s decision to pull the plug on the merger earlier this morning.
More Articles on West Penn Allegheny and Highmark:
Highmark Unveils New Health Plan With Limited UPMC Hospitals, Physicians
Highmark Builds Executive Team for West Penn Allegheny
Highmark-West Penn Alleghany Deal Sparks Shift in Physician’s Migration Patterns
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
